Induced Pluripotent Stem Cells
"Induced Pluripotent Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.
| Descriptor ID |
D057026
|
| MeSH Number(s) |
A11.872.040.500 A11.872.700.500
|
| Concept/Terms |
Fibroblast-Derived Induced Pluripotent Stem Cells- Fibroblast-Derived Induced Pluripotent Stem Cells
- Fibroblast Derived Induced Pluripotent Stem Cells
- Fibroblast-Derived IPS Cells
- Cell, Fibroblast-Derived IPS
- Cells, Fibroblast-Derived IPS
- Fibroblast Derived IPS Cells
- Fibroblast-Derived IPS Cell
- IPS Cell, Fibroblast-Derived
- IPS Cells, Fibroblast-Derived
|
Below are MeSH descriptors whose meaning is more general than "Induced Pluripotent Stem Cells".
Below are MeSH descriptors whose meaning is more specific than "Induced Pluripotent Stem Cells".
This graph shows the total number of publications written about "Induced Pluripotent Stem Cells" by people in this website by year, and whether "Induced Pluripotent Stem Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 6 | 1 | 7 |
| 2011 | 6 | 0 | 6 |
| 2012 | 3 | 1 | 4 |
| 2013 | 8 | 1 | 9 |
| 2014 | 3 | 3 | 6 |
| 2015 | 5 | 3 | 8 |
| 2016 | 5 | 7 | 12 |
| 2017 | 10 | 3 | 13 |
| 2018 | 7 | 2 | 9 |
| 2019 | 5 | 5 | 10 |
| 2020 | 6 | 9 | 15 |
| 2021 | 3 | 5 | 8 |
| 2022 | 8 | 1 | 9 |
| 2023 | 7 | 0 | 7 |
| 2024 | 9 | 4 | 13 |
| 2025 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Induced Pluripotent Stem Cells" by people in Profiles.
-
Alzheimer's disease protective allele of Clusterin modulates neuronal excitability through lipid-droplet-mediated neuron-glia communication. Mol Neurodegener. 2025 May 03; 20(1):51.
-
Identification of Hepatic-like EPO as a Cause of Polycythemia. N Engl J Med. 2025 May 01; 392(17):1684-1697.
-
An in vitro platform for characterizing axonal electrophysiology of individual human iPSC-derived nociceptors. Biosens Bioelectron. 2025 Aug 01; 281:117418.
-
The miR-290 and miR-302 clusters are essential for reprogramming of fibroblasts to induced pluripotent stem cells. Stem Cells. 2025 Feb 12; 43(2).
-
FT538, iPSC-derived NK cells, enhance AML cell killing when combined with chemotherapy. J Cell Mol Med. 2025 Jan; 29(1):e70169.
-
DLK-dependent axonal mitochondrial fission drives degeneration after axotomy. Nat Commun. 2024 12 30; 15(1):10806.
-
Enhanced osteogenic potential of iPSC-derived mesenchymal progenitor cells following genome editing of GWAS variants in the RUNX1 gene. Bone Res. 2024 Dec 06; 12(1):70.
-
Modeling antisense oligonucleotide therapy in MECP2 duplication syndrome human iPSC-derived neurons reveals gene expression programs responsive to MeCP2 levels. Hum Mol Genet. 2024 11 08; 33(22):1986-2001.
-
Photopatterning of conductive hydrogels which exhibit tissue-like properties. J Mater Chem B. 2024 Oct 17; 12(40):10272-10284.
-
MARK2 variants cause autism spectrum disorder via the downregulation of WNT/?-catenin signaling pathway. Am J Hum Genet. 2024 Nov 07; 111(11):2392-2410.